This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Alan Smith, Ph.D.
Executive Vice President, Technical Operations at Bellicum Pharmaceuticals

Profile

Alan Smith, Ph.D. has over 30 years of experience in Executive Management roles in the cell therapy space for areas that include research & development, operations, manufacturing and Quality. He is currently the Executive Vice President of Technical Operations at Bellicum Pharmaceuticals with responsibility for manufacturing, quality control, assay development, process development, facilities and supply chain. Prior to Bellicum, he served as the Vice President of Research & Development and Cellular Therapeutics for LifeNet Health and its subsidiary-- The Institute of Regenerative Medicine. He was responsible for research, product development, cell production, research tissue, and cardiovascular research for the company--including program management and general operations of the Institute. Dr. Smith previously owned a consulting business in the cell therapy industry and fulfilled numerous other senior executive management roles for cell therapy companies like: Cognate BioServices, Osiris Therapeutics, Aastrom Biosciences, Geneic Sciences, and Baxter Healthcare Corporation. He is a published co-author on numerous journal articles and has held Adjunct Professor appointments at Eastern Virginia Medical School, California State University-Long Beach and Utah State University. Dr. Smith earned his B.S. degree in Chemistry in 1976, and a Ph.D. degree in Biochemistry in 1982.


Agenda Sessions

  • Instrumentation and mechanisms to drive efficient therapies

    11:00am

Speakers at this event